April 23, 2019

April 22, 2019

Subscribe to Latest Legal News and Analysis

NIOSH Draft NORA for Respiratory Health Recommends Preventing Dust-Induced Lung Diseases, Including Those Associated with Nanomaterials

On March 15, 2018, the National Institute for Occupational Safety and Health (NIOSH) announced the availability of the draft National Occupational Research Agenda for Respiratory Health for public comment.  The National Occupational Research Agenda (NORA) is a partnership program created to stimulate innovative research and improved workplace practices.  The draft NORA for Respiratory Health is the first NORA to address respiratory health, and it is intended to identify the research, information, and actions most needed to prevent occupational injuries.  The objectives include preventing and reducing work-related interstitial/dust-induced lung diseases.  This will be achieved in part by preventing and reducing coal workers’ pneumoconiosis “and other dust-induced lung diseases, including those associated with nanomaterials.”  The draft NORA states:  “Nanomaterials, defined as having a length scale between one and 100 nanometers, exhibit unique properties that affect physical, chemical, and biological behavior.  Animal and other toxicological studies have shown adverse lung effects include inflammation and fibrosis (Maynard & Kuempel, 2005).”  According to the draft NORA, since there is no known effective treatment for any of the pneumoconioses, “primary prevention to control workplace fibrogenic dust exposures, medical surveillance for early disease detection, and other interventions from across the hierarchy of controls are essential.”  Comments on the draft NORA for Respiratory Health are due May 14,  2018. 

©2019 Bergeson & Campbell, P.C.


About this Author

Lynn Bergeson, Campbell PC, Toxic Substances Control Act Attorney, federal insecticide lawyer, industrial biotechnology legal counsel, Food Drug Administration law
Managing Partner

Owner of Bergeson & Campbell, P.C. (B&C®), Lynn L. Bergeson has earned an international reputation for her deep and expansive understanding of the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), European Union Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), and especially how these regulatory programs pertain to nanotechnology, industrial biotechnology, synthetic biology, and other emerging transformative technologies. Her knowledge of and involvement in the policy...

Carla Hutton, Bergeson Campbell PC, global regulatory attorney, public health activists lawyer, metals industry legal counsel, Toxic Substances Control Act law
Regulatory Analyst

Since 1996, Carla Hutton has monitored, researched, and written about regulatory and legislative issues that may potentially affect Bergeson & Campbell, P.C. (B&C®) clients. She is responsible for creating a number of monthly and quarterly regulatory updates for B&C's clients, as well as other documents, such as chemical-specific global assessments of regulatory developments and trends. She authors memoranda for B&C clients on regulatory and legislative developments, providing information that is focused, timely and applicable to client initiatives. These tasks have proven invaluable to many clients, keeping them aware and abreast of developing issues so that they can respond in kind and prepare for the future of their business.

Ms. Hutton brings a wealth of experience and judgment to her work in federal, state, and international chemical regulatory and legislative issues, including green chemistry, nanotechnology, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the Toxic Substances Control Act (TSCA), Proposition 65, and the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) program.